Overview

Cambrex High Point, a subsidiary of Cambrex Corporation, is a leading provider of active pharmaceutical ingredients (APIs), advanced intermediates, and drug product services for the pharmaceutical industry. The company specializes in manufacturing and development services to accelerate drug development and commercialization.

Therapeutic areas

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Cambrex High Point in our records. PharmaTek screens the full directory against live FDA enforcement data.

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.